Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border

Acta Tropica

Volumn 120, Issue 1-2, 2011, Pages 130-135

  Phompradit, Papichaya ^a   Wisedpanichkij, Raewadee ^a   Muhamad, Poonuch ^a   Chaijaroenkul, Wanna ^a   Na Bangchang, Kesara ^a  

^a THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Gene amplification; Multidrug resistance; Pfatp6; Pfmdr1; Plasmodium falciparum; Single nucleotide polymorphism

Indexed keywords

ARTESUNATE; CHLOROQUINE; MEFLOQUINE; QUININE;

ALLELE; DRUG RESISTANCE; MOLECULAR ANALYSIS; PARASITE; POLYMERASE CHAIN REACTION; POLYMORPHISM;

ALLELE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CODON; DNA POLYMORPHISM; GENE AMPLIFICATION; GENE DOSAGE; GENE MUTATION; GENETIC ASSOCIATION; IC 50; IN VITRO STUDY; MICROBIAL GENETICS; NONHUMAN; PARASITE ISOLATION; PFATP6 GENE; PFMDR1 GENE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THAILAND; WILD TYPE;

ANTIMALARIALS; ARTEMISININS; CALCIUM-TRANSPORTING ATPASES; CHLOROQUINE; DRUG RESISTANCE; GENETIC MARKERS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MEFLOQUINE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MYANMAR; PARASITIC SENSITIVITY TESTS; PHARMACOGENETICS; PLASMODIUM FALCIPARUM; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; QUININE; THAILAND;

MYANMAR; THAILAND;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 80052095101     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.07.003     Document Type: Article

References (44)

1. Alker A.P., Lim P., Sem R., Shah N.K., Yi P., Bouth D.M., Tsuyuoka R., Maguire J.D., Fandeur T., Ariey F., Wongsrichanalai C., Meshnick S.R. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am. J. Trop. Med. Hyg. 2007, 76:641-647.
2. Babiker H.A., Pringle S.J., Abdel-Muhsin A., Mackinnon M., Hunt P., Walliker D. High-level chloroquine resistance in Sudanese isolates of Plasmodium falciparum is associated with mutations in the chloroquine resistance transporter gene pfcrt and the multidrug resistance Gene pfmdr1. J. Infect. Dis. 2001, 183:1535-1538.
3. Basco L.K., Ringwald P. pfmdr1 gene mutation and clinical response to chloroquine in Yaounde, Cameroon. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:210-211.
4. Bennett T.N., Paguio M., Gligorijevic B., Seudieu C., Kosar A.D., Davidson E., Roepe P.D. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Antimicrob. Agents Chemother. 2004, 48:1807-1810.
5. Cerutti Junior C., Marques C., Alencar F.E., Durlacher R.R., Alween A., Segurado A.A., Pang L.W., Zalis M.G. Antimalarial drug susceptibility testing of Plasmodium falciparum in Brazil using a radioisotope method. Mem. Inst. Oswaldo Cruz 1999, 94:803-809.
6. Chaijaroenkul W., Na-Bangchang K.N., Mungthin M., Ward S.A. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003. Malar. J. 2005, 4:37-43.
7. Chaijaroenkul W., Wisedpanichkij R., Na-Bangchang K. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate. Acta Trop. 2010, 113:190-194.
8. Chen N., Russell B., Fowler E., Peters J., Cheng Q. Levels of chloroquine resistance in Plasmodium falciparum are determined by loci other than pfcrt and pfmdr1. J. Infect. Dis. 2002, 185:405-407.
9. Duraisingh M.T., Cowman A.F. Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop. 2005, 94:181-190.
10. Duraisingh M.T., Jones P., Sambou I., von Seidlein L., Pinder M., Warhurst D.C. The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin. Mol. Biochem. Parasitol. 2000, 108:13-23.
11. Durand R., Jafari S., Vauzelle J., Delabre J.F., Jesic Z., Le, Bras.J. Analysis of pfcrt point mutations and chloroquine susceptibility in isolates of Plasmodium falciparum. Mol. Biochem. Parasitol. 2001, 114:95-102.
12. Ferreira I.D., Martinelli A., Rodrigues L.A., do Carmo E.L., do Rosario V.E., Povoa M.M., Cravo P. Plasmodium falciparum from Para state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. Trop. Med. Int. Health 2008, 13:199-207.
13. Ferreira I.D., Rosario V.E., Cravo P.V. Real-time quantitative PCR with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malar. J. 2006, 5:1-7.
14. Foote S.J., Kyle D.E., Martin R.K., Oduola A.M., Forsyth K., Kemp D.J., Cowman A.F. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 1990, 345:255-258.
15. Haruki K., Bray P.G., Ward S.A., Hommel M., Ritchie G.Y. Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr1 gene. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:694-698.
16. Hyde J.E. Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs. Microbes Infect. 2002, 4:165-174.
17. Jambou R., Legrand E., Niang M., Khim N., Lim P., Volney B., Ekala M.T., Bouchier C., Esterre P., Fandeur T., Mercereau-Puijalon O. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 2005, 366:1960-1963.
18. Le Bras J., Durand R. The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam. Clin. Pharmacol. 2003, 17:147-153.
19. Mita T., Kaneko A., Hombhanje F., Hwaihwanje I., Takahashi N., Osawa H., Tsukahara T., Masta A., Lum J.K., Kobayakawa T., Ishizaki T., Björkman A. Role of pfmdr1 mutations on chloroquine resistance in Plasmodium falciparum isolates with pfcrt K76T from Papua New Guinea. Acta Trop. 2006, 98:137-144.
20. Mu J., Ferdig M.T., Feng X., Joy D.A., Duan J., Furuya T., Subramanian G., Aravind L., Cooper R.A., Wootton J.C., Xiong M., Su X.Z. Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol. Microbiol. 2003, 49:977-989.
21. Mugittu K., Genton B., Mshinda H., Beck H.P. Molecular monitoring of Plasmodium falciparum resistance to artemisinin in Tanzania. Malar. J. 2006, 5:126-134.
22. Mungthin M., Suwandittakul N., Chaijaroenkul W., Rungsrihirunrat K., Harnyuttanakorn P., Seugorn A., et al. The patterns of mutation and amplification of Plasmodium falciparum pfcrt and pfmdr1 genes in Thailand during the year 1988 to 2003. Parasitol. Res. 2010, 107:539-545.
23. Na-Bangchang K., Congpuong K. Current malaria status and distribution of drug resistance in East and Southeast Asia with special focus to Thailand. Tohoku J. Exp. Med. 2007, 211:99-113.
24. Na-Bangchang K., Ruengweerayut R., Mahamad P., Ruengweerayut K., Chaijaroenkul W. Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border. Malar. J. 2010, 9:273-279.
25. Nagesha H.S., Din S., Casey G.J., Susanti A.I., Fryauff D.J., Reeder J.C., Cowmanm A.F. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in-vivo drug resistance in West Papua, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:43-49.
26. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., Fukuda M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 2008, 359:2619-2620.
27. Noedl H., Socheat D., Satimai W. Artemisinin-resistant malaria in Asia. N. Engl. J. Med. 2009, 361:540-541.
28. Nosten F., Luxemburger C., ter Kuile F.O., Woodrow C., Eh J.P., Chongsuphajaisiddhi T., White N.J. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 1994, 170:971-977.
29. Pickard A.L., Wongsrichanalai C., Purfield A., Kamwendo D., Emery K., Zalewski C., Kawamoto F., Miller R.S., Meshnick S.R. Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob. Agents Chemother. 2003, 47:2418-2423.
30. Pillai D.R., Labbe A.C., Vanisaveth V., Hongvangthong B., Pomphida S., Inkathone S., Zhong K., Kain K.C. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J. Infect. Dis. 2001, 183:789-795.
31. Price R.N., Cassar C., Brockman A., Duraisingh M., van Vugt M., White N.J., Nosten F., Krishna S. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 1999, 43:2943-2949.
32. Price R.N., Uhlemann A.C., Brockman A., McGready R., Ashley E., Phaipun L., Patel R., Laing K., Looareesuwan S., White N.J., Nosten F., Krishna S. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004, 364:438-447.
33. Price R.N., Uhlemann A.C., van Vugt M., Brockman A., Hutagalung R., Nair S., Nash D., Singhasivanon P., Anderson T.J., Krishna S., White N.J., Nosten F. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. Clin. Infect. Dis. 2006, 42:1570-1577.
34. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000, 403:906-909.
35. Sidhu A.B., Valderramos S.G., Fidock D.A. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol. Microbiol. 2005, 57:913-926.
36. Smilkstein M., Sriwilaijaroen N., Kelly J.X., Wilairat P., Riscoe M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 2004, 48:1803-1806.
37. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science 1976, 193:673-675.
38. Thomas S.M., Ndir O., Dieng T., Mboup S., Wypij D., Maguire J.H., Wirth D.F. In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal. Am. J. Trop. Med. Hyg. 2002, 66:474-480.
39. Uhlemann A.C., Cameron A., Eckstein-Ludwig U., Fischbarg J., Iserovich P., Zuniga F.A., East M., Lee A., Brady L., Haynes R.K., Krishna S. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat. Struct. Mol. Biol. 2005, 12:628-629.
40. Vijaykadga S., Rojanawatsirivej C., Cholpol S., Phoungmaneem D., Nakavej A., Wongsrichanalai C. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop. Med. Int. Health 2003, 11:211-219.
41. von Seidlein L., Duraisingh M.T., Drakeley C.J., Bailey R., Greenwood B.M., Pinder M. Polymorphism of the Pfmdr1 gene and chloroquine resistance in Plasmodium falciparum in The Gambia. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:450-453.
42. Wooden J., Kyes S., Sibley C.H. PCR and strain identification in Plasmodium falciparum. Parasitol. Today 1993, 9:303-305.
43. Zalis M.G., Pang L., Silveira M.S., Milhous W.K., Wirth D.F. Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am. J. Trop. Med. Hyg. 1998, 58:630-637.
44. Zhang G.Q., Guan Y.Y., Zheng B., Wu S., Tang L.H. No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China. Malar. J. 2008, 8:7-12.